This retrospective study from Memorial Sloan-Kettering examines 186 patients with metastatic epidural spinal cord compression (ESCC) who underwent separation surgery followed by postoperative SRS. It asks which radiation dose and fractionation scheme best achieves durable local tumor control after this limited decompression procedure.
Before this paradigm, postoperative conventional EBRT (30 Gy in 10 fractions) was standard after spinal decompression, but yielded local recurrence in up to 70% of patients at one year. The recognition that aggressive gross total resection also failed to provide durable control drove the search for a better combined approach.
When you have a patient with high-grade ESCC from a radioresistant tumor (renal cell, sarcoma, melanoma), separation surgery followed by high-dose SRS is the target strategy. The goal of surgery is NOT gross total resection — it is restoring a 2-3 mm CSF space around the cord so tumoricidal SRS doses can be safely delivered.
Use high-dose hypofractionated SRS (24-30 Gy in 3 fractions) when possible; this is the regimen that drives local progression below 5% at one year. Do not let prior radiation failure or radioresistant histology dissuade you from this approach. Neither predicts worse outcomes after SRS.
This paper is the large-cohort validation of the separation surgery concept first described in the Moulding et al. 21-patient pilot, and it directly supports the NOMS framework for surgical decision-making in spinal oncology.
This retrospective study from Memorial Sloan-Kettering examines 186 patients with metastatic epidural spinal cord compression (ESCC) who underwent separation surgery followed by postoperative SRS. It asks which radiation dose and fractionation scheme best achieves durable local tumor control after this limited decompression procedure.
Before this paradigm, postoperative conventional EBRT (30 Gy in 10 fractions) was standard after spinal decompression, but yielded local recurrence in up to 70% of patients at one year. The recognition that aggressive gross total resection also failed to provide durable control drove the search for a better combined approach.
When you have a patient with high-grade ESCC from a radioresistant tumor (renal cell, sarcoma, melanoma), separation surgery followed by high-dose SRS is the target strategy. The goal of surgery is NOT gross total resection — it is restoring a 2-3 mm CSF space around the cord so tumoricidal SRS doses can be safely delivered.
Use high-dose hypofractionated SRS (24-30 Gy in 3 fractions) when possible; this is the regimen that drives local progression below 5% at one year. Do not let prior radiation failure or radioresistant histology dissuade you from this approach. Neither predicts worse outcomes after SRS.
This paper is the large-cohort validation of the separation surgery concept first described in the Moulding et al. 21-patient pilot, and it directly supports the NOMS framework for surgical decision-making in spinal oncology.